In details, SRg3 inhibits the phosphorylation of ERK and Akt, as well as induces the instability of mutant p53, thereby blocking NF-κB signal transduction, which in turn decreases the expression of Bcl-2 and ultimately induces apoptosis of BC cells (Kim et al., 2014). The gene discussed is NFKB1; the disease is breast cancer.